Myriad Genetics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of MYGN for the last quarter is 196.60 M USD, and it's 2.45% higher compared to the previous quarter. The net income of Q4 23 is -31.20 M USD.